|
|
|
Volumn 11, Issue 4, 2013, Pages 175-177
|
|
Predicting locoregional recurrence after neoadjuvant chemotherapy in patients with breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
PROGESTERONE RECEPTOR;
ADJUVANT CHEMOTHERAPY;
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER RECURRENCE;
HISTOLOGY;
HUMAN;
MULTIPLE CYCLE TREATMENT;
NOMOGRAM;
NOTE;
PARTIAL MASTECTOMY;
PREDICTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SURVIVAL;
TREATMENT RESPONSE;
TUMOR VOLUME;
DRUG RESPONSE;
PREVALENCE;
RECURRENT DISEASE;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
NEOADJUVANT THERAPY;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
RESEARCH DESIGN;
RISK;
TREATMENT OUTCOME;
|
|
EID: 84878310113
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
